viru
discoveri
base
cdnaaflp
amplifi
fragment
length
polymorph
vidisca
novel
approach
provid
fast
effect
tool
amplif
unknown
genom
eg
human
pathogen
virus
vidisca
method
base
doubl
restrict
enzym
process
target
sequenc
ligat
oligonucleotid
adaptor
subsequ
serv
prime
site
amplif
method
base
common
presenc
restrict
site
result
gener
reproduc
speciesspecif
amplif
pattern
method
allow
amplif
identif
viral
rnadna
lower
cutoff
valu
copiesml
dna
virus
copiesml
rna
virus
previous
describ
identif
novel
human
coronaviru
use
vidisca
method
date
still
varieti
human
diseas
unknown
etiolog
includ
sever
chronic
diseas
amyotroph
later
sclerosi
al
multipl
sclerosi
ms
also
acut
infect
kawasaki
diseas
multipl
respiratori
diseas
viral
origin
suggest
mani
diseas
emphas
import
continu
search
new
virus
identif
previous
unrecogn
viral
agent
patient
sampl
great
medic
interest
remain
major
technic
challeng
identif
novel
viral
pathogen
difficult
viru
discoveri
tool
known
date
sever
problem
encount
search
new
virus
first
unidentifi
virus
replic
vitro
least
cell
commonli
use
viral
diagnost
second
molecular
biolog
techniqu
previous
employ
identifi
unknown
virus
specif
drawback
sever
techniqu
use
viru
discoveri
eg
univers
primer
pcr
random
prime
base
pcr
represent
differ
analysi
rda
although
everi
techniqu
proven
use
viru
discoveri
certain
circumst
seriou
limit
restrict
univers
pcr
primer
amplifi
new
member
alreadi
known
viru
famili
method
two
major
drawback
first
choic
specif
viru
famili
made
limit
possibl
identifi
member
unsuspect
famili
found
member
total
new
one
second
univers
primer
may
simpli
match
genom
sequenc
novel
member
viru
famili
illustr
lack
success
univers
coronaviru
primer
design
new
memberssarscov
identifi
none
studi
use
primer
abl
detect
novel
human
coronaviru
obvious
primer
gradual
improv
famili
member
known
anoth
techniqu
use
nonspecif
amplif
viral
sequenc
random
prime
pcr
low
anneal
temperatur
howev
ingredi
assay
contain
contamin
dna
instanc
enzym
use
may
contain
trace
amount
dna
bacteria
produc
contamin
dna
also
amplifi
therefor
possibl
determin
earli
stage
whether
amplif
product
repres
new
viru
contamin
nucleic
acid
resolv
excess
clone
sequenc
therefor
high
throughput
screen
mani
clinic
sampl
impract
moreov
techniqu
success
virus
replic
vitro
case
cell
cultur
supernat
use
input
assay
represent
differ
analysi
rda
subtract
hybrid
techniqu
enrich
nucleic
acid
sequenc
present
one
tissu
absent
present
lower
concentr
otherwis
ident
tissu
sampl
rda
util
pcr
gener
set
nucleic
acid
target
neg
control
tester
sampl
subtract
hybrid
select
amplif
targetenrich
sequenc
method
develop
tissu
materi
nontissu
sampl
serumplasma
viru
cultur
supernat
fact
liquid
sampl
low
concentr
dna
rna
tester
sampl
may
restrain
select
amplif
unknown
viral
target
disadvantag
techniqu
requir
neg
control
tissu
person
diseas
tissu
obtain
recent
develop
gener
simpl
easi
use
new
viru
discoveri
method
allow
largescal
screen
rna
dna
viru
sampl
serumplasma
viru
cultur
supernat
method
base
cdnaaflp
techniqu
viru
discoveri
cdnaaflp
vidisca
main
featur
vidisca
prior
knowledg
genom
sequenc
requir
presenc
restrict
enzym
site
suffici
guarante
pcr
amplif
vidisca
begin
treatment
select
enrich
viral
nucleic
acid
includ
centrifug
step
remov
residu
cell
mitochondria
fig
addit
dnase
treatment
use
remov
interf
chromosom
dna
mitochondri
dna
degrad
cell
wherea
rnase
sampl
degrad
rna
step
viral
nucleic
acid
specif
protect
within
viral
particl
next
dnasernas
inactiv
viral
nucleic
acid
subsequ
extract
particl
rna
revers
transcrib
cdna
secondstrand
synthesi
perform
make
dsdna
viral
rna
dna
genom
dsdna
digest
frequent
cut
restrict
enzym
like
present
everi
viral
target
msei
mseianchor
ligat
digest
dna
essenti
method
restrict
enzym
remain
activ
ligas
reaction
thu
prevent
concatamer
digest
fragment
anchor
remov
design
way
restrict
site
lost
target
subsequ
pcramplifi
primer
anneal
anchor
sequenc
follow
round
select
amplif
primer
extend
one
nucleotid
g
c
thu
primer
combin
use
sampl
compar
repres
neg
control
neg
serum
plasma
supernat
uninfect
cultur
pcr
fragment
specif
infect
clinic
sampl
clone
sequenc
amplif
base
presenc
restrict
site
pcr
reproduc
duplic
sampl
fragment
amplifi
pcr
product
distinguish
background
amplif
assay
rel
highthroughput
multipl
sampl
ten
test
per
cycl
vidisca
abl
amplifi
viral
nucleic
acid
edtaplasma
person
hepat
b
viru
infect
person
acut
parvoviru
infect
use
urin
could
detect
adenovir
dna
influenza
b
rna
two
patient
techniqu
also
detect
picornavirus
cell
cultur
result
illustr
vidisca
techniqu
capac
identifi
rna
dna
virus
directli
patient
materi
cell
cultur
fact
first
experi
suspect
viru
cultur
led
identif
novel
human
coronaviru
three
human
coronavirus
known
time
sarscov
repres
fourth
speci
rapid
identif
novel
coronaviru
demonstr
power
viru
discoveri
tool
use
test
larg
sampl
set
suspect
contain
viral
pathogen
min
order
remov
cell
cell
debri
insolubl
particl
mucu
everi
analyz
sampl
test
duplic
everi
experi
appropri
neg
control
includ
neg
control
sampl
type
deriv
healthi
person
virusneg
cell
cultur
cell
type
pathogen
cultur
immedi
centrifug
l
sampl
transfer
fresh
tube
care
taken
pellet
materi
transfer
sampl
except
full
cellsinsolubl
materi
primal
volum
may
increas
need
dnase
treatment
dnase
solut
prepar
nucleic
acid
free
environ
mix
l
dnase
enzym
l
dnase
buffer
l
steril
water
per
l
origin
sampl
subsequ
dnase
solut
ad
sampl
materi
incub
c
min
immedi
dnase
treatment
l
solut
ad
sampl
lyse
materi
see
note
lysi
done
room
temperatur
min
sampl
thoroughli
mix
invert
vortex
l
silica
ad
sampl
incub
room
temperatur
gentl
shake
min
sampl
centrifug
rpm
sec
pellet
silica
particl
supernat
discard
pellet
silica
wash
twice
l
addit
solut
sampl
vortex
thoroughli
pellet
larg
particl
visibl
centrifug
sec
rpm
wash
necessari
remov
trace
edta
may
inhibit
follow
enzymat
reaction
sampl
wash
twice
room
temperatur
ethanol
aceton
manner
describ
ethanol
ad
wash
guandin
thiocyan
residu
trace
deterg
edta
wherea
aceton
wash
need
primarili
speed
dri
process
remov
aceton
silica
dri
min
c
lid
open
elut
bound
nucleic
acid
l
steril
water
ad
sampl
vortex
silica
particl
suspens
incub
c
min
shake
rpm
elut
sampl
centrifug
min
rpm
l
liquid
fraction
transfer
fresh
tube
sampl
store
c
need
revers
transcript
rt
reaction
mixtur
assembl
nucleic
acid
nucleas
free
condit
consist
twostep
reaction
rt
reaction
result
singlestrand
cdna
use
templat
restrict
enzym
cleavag
adaptor
ligat
therefor
secondstrand
synthesi
perform
use
rnase
h
digest
residu
rna
sequenas
enzym
synthes
second
strand
dna
digest
dscdna
perform
restrict
enzym
protocol
describ
includ
digest
msei
enzym
combin
may
alter
use
two
differ
restrict
enzym
essenti
observ
fragment
cleav
side
enzym
less
chanc
amplifi
pcr
one
plan
chang
enzym
combin
care
taken
combin
restrict
enzym
gener
restrict
fragment
virtual
templat
inactiv
step
digest
ligat
restrict
activ
prevent
gener
concatamer
form
target
templat
fragment
properli
ligat
adaptor
cleav
point
mutat
introduc
fig
ligat
perform
h
c
main
part
vidisca
method
amplif
genet
materi
without
prior
knowledg
sequenc
preprocess
dscdna
adaptor
amplifi
use
primer
specif
adaptor
develop
method
determin
singl
pcr
round
provid
suffici
specif
sensit
second
nest
pcr
includ
protocol
pcr
use
primer
similar
primer
use
first
pcr
one
nucleotid
ad
end
primer
first
pcr
reaction
done
standard
pcr
thermocycl
program
tabl
optim
l
reaction
tabl
see
note
success
thermocycl
sampl
store
c
need
second
pcrselect
amplif
second
nest
pcr
reaction
necessari
provid
high
specif
sensit
select
pcr
perform
primer
sequenc
ident
standard
primer
addit
nucleotid
part
addit
nucleotid
outsid
adaptor
sequenc
thu
belong
unknown
materi
fig
use
addit
nucleotid
allow
separ
reaction
differ
primer
combin
enabl
better
analysi
sampl
select
requir
one
want
amplifi
fragment
match
thermocycl
profil
design
increas
specif
reaction
use
start
anneal
temperatur
c
gradual
decreas
first
ten
cycl
c
pcr
mix
prepar
describ
l
per
sampl
hinpix
mseix
primer
denot
primer
addit
nucleotid
tabl
see
note
pcr
product
may
analyz
immedi
store
c
need
second
pcr
product
analyz
agaros
gel
gener
fragment
less
bp
size
owe
need
highqual
separ
small
differ
fragment
size
metaphor
agaros
use
allow
differenti
among
fragment
vari
bp
size
addit
metaphor
agaros
provid
easi
setup
highthroughput
process
gel
analysi
purif
compar
polyacrylamid
gel
metaphor
agaros
gel
prepar
describ
ml
concentr
tbe
buffer
pour
erlenmey
flask
stir
magnet
stirrer
g
metaphor
agaros
weight
gentli
pour
erlenmey
flask
mix
addit
agaros
powder
result
clump
agaros
solut
stir
anoth
min
soak
agaros
grain
heat
microwav
sec
low
power
primari
heat
agaros
stir
heat
cycl
low
power
extens
stir
agaros
solubil
final
heat
step
sec
medium
power
agaros
cool
c
l
ethidium
bromid
mgml
ad
agaros
pour
electrophoresi
tray
comb
insert
crucial
remov
air
bubbl
gel
eg
pipett
tip
agaros
solidifi
room
temperatur
incub
c
least
min
incub
c
improv
gel
resolut
gel
posit
electrophoresi
box
fill
tbe
buffer
l
second
pcr
product
mix
l
load
buffer
sampl
layer
prepar
agaros
gel
l
ladder
use
dna
size
marker
electrophoret
separ
perform
v
h
immedi
electrophoresi
complet
gel
analyz
uv
transillumin
pictur
taken
analysi
gel
store
c
wrap
plastic
saran
wrap
pictur
gel
use
search
fragment
present
sampl
interest
control
sampl
fragment
present
exclus
sampl
interest
mark
pictur
fig
band
appear
faint
gel
pcr
product
concentr
vacuum
centrifug
reanalyz
metaphor
gel
fragment
select
gel
posit
uv
transillumin
select
band
excis
steril
razor
mg
per
slice
store
code
eppendorf
tube
c
see
note
excis
band
second
pictur
gel
taken
document
proper
excis
dna
fragment
gel
extract
qiaquick
gel
extract
kit
follow
manufactur
protocol
gel
slice
solubil
l
qg
buffer
l
isopropanol
ad
extract
result
dna
dissolv
l
eb
buffer
altern
gel
extract
method
may
use
l
suspend
e
coli
bacteria
bhi
medium
ad
pcr
mixtur
thermocycl
perform
describ
tabl
pcr
complet
l
pcr
product
mix
gel
load
dye
analyz
agaros
mp
gel
smart
ladder
dna
size
marker
repres
pictur
gel
shown
fig
lane
seem
contain
plasmid
proper
insert
select
correspond
pcr
product
subject
sequenc
reaction
sequenc
reaction
perform
colonypcr
product
bigdy
chemistri
use
revers
primer
accord
manufactur
instruct
appli
biosystem
sequenc
data
obtain
survey
analyz
blast
server
http
wwwncbinlmnihgovblast
raw
sequenc
edit
remov
sequenc
deriv
vector
adaptor
procedur
done
manual
use
design
program
eg
codoncod
http
wwwcodoncodecom
cleanup
sequenc
analyz
qualiti
show
clear
singl
signal
export
fasta
format
analysi
import
bioedit
program
http
wwwmbioncsuedubioeditbioedithtml
sequenc
subject
batch
blast
analysi
default
set
batch
analysi
allow
preselect
sequenc
interest
mrna
rrna
fragment
frequent
found
background
result
indic
presenc
viru
unknown
sequenc
select
reanalyz
blast
server
nblast
expect
number
databas
result
still
clear
follow
step
might
taken
sequenc
tblastx
rpsblast
display
similar
viral
sequenc
consid
possibl
unknown
pathogen
sequenc
analyz
viral
databas
care
taken
hit
virtual
fragment
show
similar
viral
sequenc
case
pathogen
might
consid
identifi
result
differ
fragment
one
sampl
show
similar
viru
famili
case
essenti
design
diagnost
primer
set
retest
origin
materi
presenc
pathogen
pathogen
detect
diagnost
rt
pcr
origin
sampl
effort
sequenc
entir
genom
undertaken
nucleic
acid
isol
highli
effici
method
may
use
advis
use
trizol
isol
intend
isol
nucleic
acid
cell
tissu
buffer
lysi
suffici
inactiv
viru
incub
safe
process
sampl
normal
biochemistri
laboratori
buffer
contain
concentr
guanidin
thiocyan
gtc
thu
consid
highli
toxic
rememb
store
gtc
wast
separ
addit
onetenth
volum
n
sodium
hydroxid
prevent
gtc
degrad
rna
cdna
handl
first
pcr
perform
nucleicacidfre
environ
sequenc
independ
amplif
result
overamplif
contamin
dna
use
chlorin
decontamin
limit
may
decreas
viabil
revers
transcript
enzym
thermocycl
perform
pcr
machin
includ
heat
cover
two
drop
paraffin
oil
layer
top
pcr
solut
prevent
evapor
pcr
reaction
advis
use
fresh
razor
band
excis
exposur
gel
uv
light
limit
exposur
result
dna
degrad
